The Tunisian population history through the Crigler-Najjar type I syndrome

被引:12
作者
Petit, Francois M. [1 ]
Bezieau, Stephane [2 ]
Gajdos, Vincent [3 ]
Parisot, Frederic [1 ]
Scoul, Catherine [2 ]
Capel, Liliane [1 ]
Stozinic, Volodia [1 ]
Khrouf, Naima [4 ]
M'Rad, Ridha [5 ]
Koshy, Abraham [6 ,7 ]
Mollet-Boudjemline, Alix [3 ]
Francoual, Jeanne [1 ]
Labrune, Philippe [3 ]
机构
[1] Univ Paris 11, Antoine Beclere Hosp, AP HP, UFR Kremlin Bicetre,Dept Biochem Hormonol & Genet, F-92141 Clamart, France
[2] Fac Med, Lab Etud Polymorphisme ADN EA3823, Nantes, France
[3] Univ Paris 11, Antoine Beclere Hosp, AP HP,Dept Paediat & Genet,UFR Kremlin Bicetre, Ctr Reference Malad Hereditaires Metab Hepat, F-92141 Clamart, France
[4] Ctr Matern & Neonatol Tunis, Dept Neonatol, El Jebri, Tunisia
[5] Charles Nicolle Hosp, Dept Congenital Dis, Tunis, Tunisia
[6] Lakeshore Hosp, Div Hepatol, Maradu, Kochi, India
[7] Res Ctr Ltd, Maradu, Kochi, India
关键词
Crigler-Najjar syndrome; founder effect; Arab world;
D O I
10.1038/sj.ejhg.5201989
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Crigler-Najjar syndrome type I (CN-I) is a rare and severe metabolic disorder. A recurrent mutation c.1070A>G in exon 3 - was identified in the Tunisian population, suggesting a founder effect. In 2004, the detection of this mutation in two Kuwaiti Bedouin families has called the Tunisian founder effect in question again. To determine the origin of this mutation, 21 Tunisian and 2 Kuwaiti Bedouin CN-I patients were screened using nine genetic markers. Haplotype analysis confirmed the founder effect hypothesis and dated the appearance of this mutation some 32 generations ago in the Tunisian population. Using the same genetic analysis, the ancestor haplotype was identified in these two families. This result genetically confirms the blending of the Bedouin nomads within today's Tunisian population. After population migration from east to west, this mutation was introduced into the Tunisian population, and then perpetuated, probably because of marriages in isolated communities.
引用
收藏
页码:848 / 853
页数:6
相关论文
共 24 条
[1]  
Al Shurafa H, 2002, CLIN TRANSPLANT, V16, P222
[3]   UGT1A1*28 allele and coronary heart disease:: The Rotterdam study [J].
Bosma, PJ ;
van der Meer, IM ;
Bakker, CT ;
Hofman, A ;
Paul-Abrahamse, M ;
Witteman, JC .
CLINICAL CHEMISTRY, 2003, 49 (07) :1180-1181
[4]   SEQUENCE OF EXONS AND THE FLANKING REGIONS OF HUMAN BILIRUBIN-UDP-GLUCURONOSYLTRANSFERASE GENE-COMPLEX AND IDENTIFICATION OF A GENETIC MUTATION IN A PATIENT WITH CRIGLER-NAJJAR SYNDROME, TYPE-I [J].
BOSMA, PJ ;
CHOWDHURY, NR ;
GOLDHOORN, BG ;
HOFKER, MH ;
ELFERINK, RPJO ;
JANSEN, PLM ;
CHOWDHURY, JR .
HEPATOLOGY, 1992, 15 (05) :941-947
[5]   Age and origin of the FCMD 3′-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population [J].
Colombo, R ;
Bignamini, AA ;
Carobene, A ;
Sasaki, J ;
Tachikawa, M ;
Kobayashi, K ;
Toda, T .
HUMAN GENETICS, 2000, 107 (06) :559-567
[6]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[7]   A COMPARISON OF LINKAGE DISEQUILIBRIUM MEASURES FOR FINE-SCALE MAPPING [J].
DEVLIN, B ;
RISCH, N .
GENOMICS, 1995, 29 (02) :311-322
[8]   Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene [J].
Francoual, J ;
Rivierre, A ;
Mokrani, C ;
Khrouf, N ;
Gottrand, F ;
Myara, A ;
Le Bihan, B ;
Capel, L ;
Lindenbaum, A ;
Labrune, P .
HUMAN MUTATION, 2002, 19 (05) :570-571
[9]   Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM Study [J].
Gaidos, Vincent ;
Petit, Francois M. ;
Perret, Claire ;
Mollet-Boudjemline, Alix ;
Colin, Patrice ;
Capel, Liliane ;
Nicaud, Viviane ;
Evans, Alun ;
Arveiler, Dominique ;
Parisot, Frederic ;
Francoual, Jeanne ;
Genin, Emmanuelle ;
Cambien, Francois ;
Labrune, Philippe .
CLINICAL CHEMISTRY, 2006, 52 (12) :2313-2314
[10]   Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus [J].
Gong, QH ;
Cho, JW ;
Huang, T ;
Potter, C ;
Gholami, N ;
Basu, NK ;
Kubota, S ;
Carvalho, S ;
Pennington, MW ;
Owens, IS ;
Popescu, NC .
PHARMACOGENETICS, 2001, 11 (04) :357-368